Status:
WITHDRAWN
Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.
Lead Sponsor:
Cornea Research Foundation of America
Conditions:
Fuchs' Endothelial Dystrophy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
With the increasing popularity of endothelial keratoplasty, a coincident increase in the rate of fungal infections post-keratoplasty has been seen in the United States. In this study, the eye bank wil...
Eligibility Criteria
Inclusion
- Male or female at least 18 years of age and any race or ethnicity
- Scheduled to have Descemet membrane endothelial keratoplasty
Exclusion
- History of glaucoma surgery in operative eye
- Known allergy or intolerance to amphotericin B
- Presence of anterior chamber intraocular lens
- Corneal stromal or epithelial dysfunction
- Presence of glaucoma defined as optic nerve damage as confirmed on Humphrey visual field testing or retinal nerve fiber layer analysis
- Presence of peripheral anterior synechiae
Key Trial Info
Start Date :
July 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04018417
Start Date
July 3 2019
End Date
July 3 2019
Last Update
July 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Price Vision Group
Indianapolis, Indiana, United States, 46260